MERISSA FRYE: Open Payments
NPI 1073164554 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 29 payments from 11 companies in 2025. Trend: 2023 $155 · 2024 $554 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $205 |
| GlaxoSmithKline, LLC. | 9 | $173 |
| Tactile Systems Technology Inc | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| HEARTFLOW, INC. | 1 | $30 |
| Boston Scientific Corporation | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Ozempic, TRELEGY ELLIPTA, SHINGRIX, Rybelsus, Flexitouch Plus, GVOKE HYPOPEN, ELIQUIS, FFRct.
Industry payments across TN — which companies pay providers there.
